Bibliotecas PUC-SP - Busca Integrada

Tumour necrosis factor α blocking agents in refractory adult Still's disease: an observational study of 20 cases

Yazar: Fautrel, B, Sibilia, J, Mariette, X, Combe, B, the, C
Baskı/Yayın Bilgisi 2005

Long term structural effects of combination therapy in patients with early rheumatoid arthritis: five year follow up of a prospective double blind controlled study

Yazar: Maillefert, J, Combe, B, Goupille, P, Cantagrel, A, Dougados, M
Baskı/Yayın Bilgisi 2003

Effects of moderate renal insufficiency on pharmacokinetics of methotrexate in rheumatoid arthritis patients

Yazar: Bressolle, F, Bologna, C, Kinowski, J, Sany, J, Combe, B
Baskı/Yayın Bilgisi 1998

HLA-DRB1 genes and patients with late onset rheumatoid arthritis

Yazar: Hellier, J, Eliaou, J, Daures, J, Sany, J, Combe, B
Baskı/Yayın Bilgisi 2001

Interleukin-2 in rheumatoid arthritis: production of and response to interleukin-2 in rheumatoid synovial fluid, synovial tissue and peripheral blood.

Yazar: Combe, B, Pope, R M, Fischbach, M, Darnell, B, Baron, S, Talal, N
Baskı/Yayın Bilgisi 1985

Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases.

Yazar: Combe, B, Rucheton, M, Graafland, H, Lussiez, V, Brunel, C, Sany, J
Baskı/Yayın Bilgisi 1989

HLA-DMA*0103 and HLA-DMB*0104 alleles as novel prognostic factors in rheumatoid arthritis

Yazar: Morel, J, Roch-Bras, F, Molinari, N, Sany, J, Eliaou, J, Combe, B
Baskı/Yayın Bilgisi 2004

HLA-DRB1 gene transcripts in rheumatoid arthritis

Yazar: Kerlan-Candon, S, Combe, B, Vincent, R, Clot, J, Pinet, V, Eliaou, J-F
Baskı/Yayın Bilgisi 2001

Autoantibodies predicting the outcome of rheumatoid arthritis: evaluation in two subsets of patients according to severity of radiographic damage

Yazar: Meyer, O, Combe, B, Elias, A, Benali, K, Clot, J, Sany, J, Eliaou, J
Baskı/Yayın Bilgisi 1997

Radiological damage in patients with rheumatoid arthritis on sustained remission

Yazar: Cohen, G, Gossec, L, Dougados, M, Cantagrel, A, Goupille, P, Daures, J P, Rincheval, N, Combe, B
Baskı/Yayın Bilgisi 2007

Investigation of the HLA component involved in rheumatoid arthritis (RA) by using the marker association-segregation chi-square (MASC) method: rejection of the unifying-shared-epit...

Yazar: Dizier, M H, Eliaou, J F, Babron, M C, Combe, B, Sany, J, Clot, J, Clerget-Darpoux, F
Baskı/Yayın Bilgisi 1993

Anti-heat shock protein 70 kDa and 90 kDa antibodies in serum of patients with rheumatoid arthritis

Yazar: Hayem, G, De Bandt, M, Palazzo, E, Roux, S, Combe, B, Eliaou, J, Sany, J, Kahn, M, Meyer, O
Baskı/Yayın Bilgisi 1999

Prognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective study

Yazar: Gossec, L, Dougados, M, Goupille, P, Cantagrel, A, Sibilia, J, Meyer, O, Sany, J, Daures, J, Combe, B
Baskı/Yayın Bilgisi 2004

Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage

Yazar: Meyer, O, Labarre, C, Dougados, M, Goupille, P., Cantagrel, A, Dubois, A, Nicaise-Roland, P, Sibilia, J, Combe, B
Baskı/Yayın Bilgisi 2003

Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double‐blind comparison

Yazar: Combe, B, Codreanu, C, Fiocco, U, Gaubitz, M, Geusens, P P, Kvien, T K, Pavelka, K, Sambrook, P N, Smolen, J S, Wajdula, J, Fatenejad, S
Baskı/Yayın Bilgisi 2006

Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single compone...

Yazar: Dougados, M., Combe, B., Cantagrel, A., Goupille, P., Olive, P., Schattenkirchner, M., Meusser, S, Paimela, L, Rau, R., Zeidler, H., Leirisalo-Repo, M., Peldan, K.
Baskı/Yayın Bilgisi 1999

Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised...

Yazar: Combe, B, Codreanu, C, Fiocco, U, Gaubitz, M, Geusens, P P, Kvien, T K, Pavelka, K, Sambrook, P N, Smolen, J S, Khandker, R, Singh, A, Wajdula, J, Fatenejad, S
Baskı/Yayın Bilgisi 2008

Clinical practice decision tree for the choice of the first disease modifying antirheumatic drug for very early rheumatoid arthritis: a 2004 proposal of the French Society of Rheum...

Yazar: Loët, X Le, Berthelot, J M, Cantagrel, A, Combe, B, De Bandt, M, Fautrel, B, Flipo, R M, Lioté, F, Maillefert, J F, Meyer, O, Saraux, A, Wendling, D, Guillemin, F
Baskı/Yayın Bilgisi 2006

Consensus statement on the initiation and continuation of tumour necrosis factor blocking therapies in rheumatoid arthritis(*)

Yazar: Smolen, J., Breedveld, F., Burmester, G., Combe, B., Emery, P., Kalden, J., Klareskog, L., Maini, R., Numo, R., van de Putte, L. B A, van Riel, P. L C M, Rodriguez-Valverd..., V.
Baskı/Yayın Bilgisi 2000

EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ES...

Yazar: Combe, B, Landewe, R, Lukas, C, Bolosiu, H D, Breedveld, F, Dougados, M, Emery, P, Ferraccioli, G, Hazes, J M W, Klareskog, L, Machold, K, Martin‐Mola, E, Nielsen, H, Silman, A, Smolen, J, Yazici, H
Baskı/Yayın Bilgisi 2007